BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12555064)

  • 1. Ambivalent role of BCL6 in cell survival and transformation.
    Albagli-Curiel O
    Oncogene; 2003 Jan; 22(4):507-16. PubMed ID: 12555064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The LAZ3/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB/POZ domain as an autonomous repressing domain.
    Deweindt C; Albagli O; Bernardin F; Dhordain P; Quief S; Lantoine D; Kerckaert JP; Leprince D
    Cell Growth Differ; 1995 Dec; 6(12):1495-503. PubMed ID: 9019154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells.
    Phan RT; Dalla-Favera R
    Nature; 2004 Dec; 432(7017):635-9. PubMed ID: 15577913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpressed BCL6 (LAZ3) oncoprotein triggers apoptosis, delays S phase progression and associates with replication foci.
    Albagli O; Lantoine D; Quief S; Quignon F; Englert C; Kerckaert JP; Montarras D; Pinset C; Lindon C
    Oncogene; 1999 Sep; 18(36):5063-75. PubMed ID: 10490843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylation inactivates the transcriptional repressor BCL6.
    Bereshchenko OR; Gu W; Dalla-Favera R
    Nat Genet; 2002 Dec; 32(4):606-13. PubMed ID: 12402037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of t(3;6)(q27;p21) breakpoints in B-cell non-Hodgkin's lymphoma and construction of the histone H4/BCL6 fusion gene, leading to altered expression of Bcl-6.
    Kurata M; Maesako Y; Ueda C; Nishikori M; Akasaka T; Uchiyama T; Ohno H
    Cancer Res; 2002 Nov; 62(21):6224-30. PubMed ID: 12414651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The proto-oncogene BCL-6 in normal and malignant B cell development.
    Niu H
    Hematol Oncol; 2002 Dec; 20(4):155-66. PubMed ID: 12469325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of the LAZ3 (BCL6) proto-oncogene accompanies murine skeletal myogenesis.
    Albagli-Curiel O; Dhordain P; Lantoine D; Auradé F; Quief S; Kerckaert JP; Montarras D; Pinset C
    Differentiation; 1998 Nov; 64(1):33-44. PubMed ID: 9921651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted somatic mutation of the BCL6 proto-oncogene and its impact on lymphomagenesis.
    Jardin F; Sahota SS
    Hematology; 2005 Apr; 10(2):115-29. PubMed ID: 16019457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of negative regulatory regions within the first exon and intron of the BCL6 gene.
    Kikuchi M; Miki T; Kumagai T; Fukuda T; Kamiyama R; Miyasaka N; Hirosawa S
    Oncogene; 2000 Oct; 19(42):4941-5. PubMed ID: 11039912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCL6: master regulator of the germinal center reaction and key oncogene in B cell lymphomagenesis.
    Basso K; Dalla-Favera R
    Adv Immunol; 2010; 105():193-210. PubMed ID: 20510734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PU.1 protein expression has a positive linear association with protein expression of germinal centre B cell genes including BCL-6, CD10, CD20 and CD22: identification of PU.1 putative binding sites in the BCL-6 promotor.
    Torlakovic E; Malecka A; Myklebust JH; Tierens A; Aasheim HC; Nesland JM; Smeland E; Kvaløy S; Delabie J
    J Pathol; 2005 Jul; 206(3):312-9. PubMed ID: 15892171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The BTB/POZ domain targets the LAZ3/BCL6 oncoprotein to nuclear dots and mediates homomerisation in vivo.
    Dhordain P; Albagli O; Ansieau S; Koken MH; Deweindt C; Quief S; Lantoine D; Leutz A; Kerckaert JP; Leprince D
    Oncogene; 1995 Dec; 11(12):2689-97. PubMed ID: 8545127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of internal deletions within the BCL6 gene in B-cell non-Hodgkin's lymphoma.
    Nakamura Y; Saito K; Furusawa S
    Br J Haematol; 1999 Apr; 105(1):274-7. PubMed ID: 10233393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation.
    Ye BH; Cattoretti G; Shen Q; Zhang J; Hawe N; de Waard R; Leung C; Nouri-Shirazi M; Orazi A; Chaganti RS; Rothman P; Stall AM; Pandolfi PP; Dalla-Favera R
    Nat Genet; 1997 Jun; 16(2):161-70. PubMed ID: 9171827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular anatomy of BCL6 translocations revealed by long-distance polymerase chain reaction-based assays.
    Akasaka H; Akasaka T; Kurata M; Ueda C; Shimizu A; Uchiyama T; Ohno H
    Cancer Res; 2000 May; 60(9):2335-41. PubMed ID: 10811103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells.
    Phan RT; Saito M; Basso K; Niu H; Dalla-Favera R
    Nat Immunol; 2005 Oct; 6(10):1054-60. PubMed ID: 16142238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A role for Bcl6 in immune memory development].
    Tokuhisa T
    Tanpakushitsu Kakusan Koso; 2002 Dec; 47(16 Suppl):2306-12. PubMed ID: 12518453
    [No Abstract]   [Full Text] [Related]  

  • 19. Roles of BCL6 in normal and transformed germinal center B cells.
    Basso K; Dalla-Favera R
    Immunol Rev; 2012 May; 247(1):172-83. PubMed ID: 22500840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The BCL6 proto-oncogene: a leading role during germinal center development and lymphomagenesis.
    Jardin F; Ruminy P; Bastard C; Tilly H
    Pathol Biol (Paris); 2007 Feb; 55(1):73-83. PubMed ID: 16815642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.